Accelerated and Real-Time Aging Services
Shelf-life validation of sterile barrier systems
ISO 11607 requires sterile medical device manufacturers to demonstrate the shelf life of their packaging system. Accelerated aging is used to simulate the effects of real-time aging by subjecting samples to elevated temperatures and realistic relative humidity levels for specific periods of time, thereby generating data more quickly and allowing for shorter time to market.
In parallel with accelerated aging, the manufacturer must also conduct a real-time study to validate the data generated during the accelerated aging process.
What is shelf life?
Shelf-life testing demonstrates the ability of a packaging system to maintain sterile integrity and strength over a defined period of time, and is indicated by labelling the product with a use by/expiry date.
Shelf life is defined as the length of time that a product may be stored without becoming:
- Unfit for use
- Unfit for consumption
- Unfit for sale
What is accelerated aging?
Accelerated aging is an artificial procedure used for establishing the shelf life to estimate the useful lifespan of a product when actual lifespan data is unavailable in an expedited manner.
Accelerated aging is conducted by simulated exposure of the product to elevated temperatures and realistic relative humidity levels for the equivalent period claimed for product expiration. The provisional accelerated aging expiration date will remain until real time aging results are acquired.
What is real time aging?
Real time aging is a stability testing process used to provide real data to determine the shelf life and the effects of aging on materials over time. The packaged product is exposed to storage conditions such as temperature and relative humidity to determine its shelf life. These studies are typically carried out at ambient temperature between 20°C to 25°C.
How is accelerated aging calculated according to ASTM F1980?
Accelerated aging techniques are defined on the basis that the chemical reactions involved in the deterioration of materials follow the Arrhenius reaction rate. This states that a 10°C temperature increase results in approximately two times an increase in the rate of the aging process. The accelerated aging process is based on the relationship of temperature and reaction rate where an increase in temperature increases the reaction rate.
The level of relative humidity (RH), should be included at realistic levels. When controlling humidity during an accelerated aging study, it is suggested in the standard to use a realistic level between 45% RH and 55% RH unless there are documented reasons for using other humidity levels. If other levels are used, a rationale should be documented.
- It is not recommended by the standard to age packaged products at temperatures above 60°C unless knowledge of the materials shows otherwise
- The calculated duration is normally rounded up to the nearest whole day
- Ambient temperature Real Time Temperature (TRT) is typically between 20°C to 25°C
- The aging factor of 2.0 is the most common value but other levels between 1.8 – 2.5 may be used once sufficient knowledge of the materials are known and can be justified
Product temperature storage labelling considerations:
Where a product is labeled with specific storage temperature range, the upper temperature listed should be used when calculating the accelerated aging duration. This is instead of the normal ambient temperature (TRT), which is typically 20°C or 25°C. If the labelled range is 15°C to 35°C, then the 35°C should be used as the ambient temperature TRT in the calculation.
It is recommended that minimum of two shelf-life timepoints are used. This provides a backup if post aging tests do not meet acceptance criteria for a particular timepoint.
STERIS offers a range of accelerated aging chambers, which can accommodate both large pallets and single shipping units.
What are stability studies?
Stability studies are conducted to evaluate the quality of a pharmaceutical or drug product over time to evaluate the influence of various environmental factors such as temperature, humidity, and light. Typically, under accelerated conditions, this simulates the effects of long-term storage in a shorter period of time.
STERIS also offers stability testing capabilities in accordance with ICH guidelines for pharmaceutical manufacturers.
- 25°C, 60% RH
- 30°C, 65% RH
- 30°C, 75% RH
- 40°C, 75% RH
Our technical professionals also offers guidance toward:
- Packaging evaluations and concept reviews
- Risk assessment
- Test planning and protocol development
- Evaluating prior validations and gap analysis
TechTalk: Accelerated aging and real time studies
TechTalk: Testing validation TechTalk webinars
Contact our team of experts to find out more about our Global Contract Sterilization, Testing and Validation Services.